AWARDDELIVERY ORDEROther than small business
Delivery order 75F40120F80460DRT STRATEGIES, INC.
Overview
Award facts
- Net obligations
- $3.87M
- $3,868,018of $3.87M potential value
- Outlays (paid to date)
- $3.06M
- $3.06M paid of $3.87M obligated$3,060,255
- Period of performance
- Aug 24, 2020 to Sep 15, 2024
- Ended
- Modifications
- 7
- Latest action Jul 22, 2025
- Contract type
- Delivery order
- PIID 75F40120F80460
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
DRUG REVIEW&SUBMISSION - CDER ESP PM SUPPORT, TECHNICAL LEAD, BUSINESS ANALYST, QA
Dates and value
- Award date
- Signed on Aug 24, 2020
- Potential end of performance
- Sep 14, 2024
- Current value
- $3,868,018Base and exercised options
- Potential value (if all options are exercised)
- $3,868,018
- Parent contract vehicle
- HHSM500201600047I (IDC, multiple award) — 16 orders recorded under it
Obligations by fiscal year of action
- FY2025: -$46,374 (de-obligation)
- FY2023: $1,007,855
- FY2022: $988,094
- FY2021: $968,719
- FY2020: $949,723
Total across 5 fiscal years: $3,868,018
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 22, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationARLINGTON, VA
UEIXMTHGDNB3QU5
CAGE code3PZT2
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyDRT STRATEGIES, INC.
Business types and certifications
Women-ownedWomen-owned small business (WOSB)Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationSubchapter S corporationCorporation (not tax-exempt)
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugs; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Arlington, Virginia 22203-2845
- Congressional district (place of performance)
- VA-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 7020INFORMATION TECHNOLOGY CENTRAL PROCESSING UNIT (CPU, COMPUTER, ANALOG) (product)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Labor hoursZ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Transaction history
Modification history
- Base award
- Aug 24, 2020Base obligation at award: $949,723
- Latest action
- Jul 22, 2025 — CloseoutModification P00007; obligation change -$46,374; administrative: no change in scope or value
- Latest substantive action
- Jul 17, 2023 — Option exercisedModification P00005; obligation change +$1,007,855
- Actions by type
- Base award1
- Option exercised3
- Other administrative action3
- Closeout1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$46,374
- Latest action: change in base and all options
- -$46,374
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Multiple awardM
- Parent vehicle agency
- Centers For Medicare And Medicaid Services7530
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 8
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2020/2020-0600-000
- 075-2021/2021-0600-000
- 075-2022/2022-0600-000
- 075-2023/2023-0600-000
- 075-X-0600-000
- Object classes
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression